13F

Stock

Taysha Gene Therapies, Inc.

TSHA · held by 3 managers

Reported value

$697.8K

Holders

3

+0 new · −0 exited

Holders’ est. mark

−$20.2K

Price effect on 3 books still in the name

Largest holder

$511.9K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC247.3K$511.9K−$5.15KAdded$394.5K
Leonteq Securities AG80K$160.8K−$12.2KAdded$42.1K
Marex Group plc12.5K$25.1K−$2.88KCut−$2.88K

Positions as of Q3 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.